New Zealand markets closed

BIIB Mar 2023 195.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
39.800.00 (0.00%)
As of 01:32PM EST. Market open.
Full screen
Previous close39.80
OpenN/A
Bid77.00
Ask80.40
Strike195.00
Expiry date2023-03-17
Day's range39.80 - 39.80
Contract rangeN/A
VolumeN/A
Open interest4
  • GlobeNewswire

    FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab)

    CAMBRIDGE, Mass., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced that the U.S. Food and Drug Administration (FDA) has accepted for review the abbreviated Biologics License Application (aBLA) for BIIB800, a biosimilar candidate referencing ACTEMRA®1 (tocilizumab), an anti-interleukin-6 receptor monoclonal antibody. ACTEMRA® is indicated for several indications, including moderate to severe rheumatoid arthritis in adults as well as juvenile idiopathic polyarthritis and sy

  • Zacks

    Why Is Mirati (MRTX) Down 19.9% Since Last Earnings Report?

    Mirati (MRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Zacks

    Is Biogen (BIIB) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.